Cargando…

Phenome-driven disease genetics prediction toward drug discovery

Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Li, Li, Zhang, Guo-Qiang, Xu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542779/
https://www.ncbi.nlm.nih.gov/pubmed/26072493
http://dx.doi.org/10.1093/bioinformatics/btv245
_version_ 1782386561327824896
author Chen, Yang
Li, Li
Zhang, Guo-Qiang
Xu, Rong
author_facet Chen, Yang
Li, Li
Zhang, Guo-Qiang
Xu, Rong
author_sort Chen, Yang
collection PubMed
description Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data. Results: To demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(−4)) and 81.3% (P < e(−12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn’s disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn’s disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn’s disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. Availability and implementation: nlp.case.edu/public/data/DMN Contact: rxx@case.edu
format Online
Article
Text
id pubmed-4542779
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-45427792015-08-25 Phenome-driven disease genetics prediction toward drug discovery Chen, Yang Li, Li Zhang, Guo-Qiang Xu, Rong Bioinformatics Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data. Results: To demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(−4)) and 81.3% (P < e(−12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn’s disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn’s disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn’s disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. Availability and implementation: nlp.case.edu/public/data/DMN Contact: rxx@case.edu Oxford University Press 2015-06-15 2015-06-10 /pmc/articles/PMC4542779/ /pubmed/26072493 http://dx.doi.org/10.1093/bioinformatics/btv245 Text en © The Author 2015. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0/),which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland
Chen, Yang
Li, Li
Zhang, Guo-Qiang
Xu, Rong
Phenome-driven disease genetics prediction toward drug discovery
title Phenome-driven disease genetics prediction toward drug discovery
title_full Phenome-driven disease genetics prediction toward drug discovery
title_fullStr Phenome-driven disease genetics prediction toward drug discovery
title_full_unstemmed Phenome-driven disease genetics prediction toward drug discovery
title_short Phenome-driven disease genetics prediction toward drug discovery
title_sort phenome-driven disease genetics prediction toward drug discovery
topic Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542779/
https://www.ncbi.nlm.nih.gov/pubmed/26072493
http://dx.doi.org/10.1093/bioinformatics/btv245
work_keys_str_mv AT chenyang phenomedrivendiseasegeneticspredictiontowarddrugdiscovery
AT lili phenomedrivendiseasegeneticspredictiontowarddrugdiscovery
AT zhangguoqiang phenomedrivendiseasegeneticspredictiontowarddrugdiscovery
AT xurong phenomedrivendiseasegeneticspredictiontowarddrugdiscovery